Motion Sickness Relief
NDC Package 63868-034-12
Package Information
Motion Sickness Relief is to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity adults and children 12 years and over1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctorchildren 6 to under 12 years1/2 to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctorchildren 2 to under 6 years1/2 tablet every 6-8 hours; do not exceed 1 1/2 tablets in 24 hours, or as directed by a doctor. Marketed by Chain Drug Marketing Association Inc, this product is identified by NDC 63868-034 and is authorized under FDA application M009.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63868 - Chain Drug Marketing Association Inc
- 63868-034 - Motion Sickness Relief
- 63868-034-12 - 2 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK
- 63868-034 - Motion Sickness Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63868-034). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63868-034-12 identifies a specific commercial package of 2 blister pack in 1 carton / 6 tablet in 1 blister pack of Motion Sickness Relief, labeled by Chain Drug Marketing Association Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Marketing Association Inc on December 01, 1992. The current certification is valid through May 16, 2026.
How is this Chain Drug Marketing Association Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868003412. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
